Evaluation of urinary cysteinyl leukotrienes as biomarkers of severity and putative therapeutic targets in COVID-19 patients
Introduction: Despite the likely involvement of cysteinyl leukotrienes (CysLTs) in progressing COVID-19, they remain scarcely explored in this context. We aimed to evaluate urinary CysLT (U-CysLTs) as severity biomarkers and putative therapeutic targets in hospitalized COVID-19 patients. The impact...
Autor principal: | |
---|---|
Formato: | masterThesis |
Idioma: | eng |
Publicado em: |
2022
|
Assuntos: | |
Texto completo: | https://hdl.handle.net/10216/142149 |
País: | Portugal |
Oai: | oai:repositorio-aberto.up.pt:10216/142149 |